Takuo Ogihara

2.6k total citations
120 papers, 2.1k citations indexed

About

Takuo Ogihara is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Takuo Ogihara has authored 120 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Oncology, 43 papers in Molecular Biology and 19 papers in Pharmacology. Recurrent topics in Takuo Ogihara's work include Drug Transport and Resistance Mechanisms (54 papers), Pharmacogenetics and Drug Metabolism (14 papers) and Pharmacological Effects and Toxicity Studies (11 papers). Takuo Ogihara is often cited by papers focused on Drug Transport and Resistance Mechanisms (54 papers), Pharmacogenetics and Drug Metabolism (14 papers) and Pharmacological Effects and Toxicity Studies (11 papers). Takuo Ogihara collaborates with scholars based in Japan, United States and United Kingdom. Takuo Ogihara's co-authors include Kentarô Yano, Ikumi Tamai, Hitomi Takanaga, Kayoko Ohura, Teruko Imai, Yoshimichi Sai, Chihaya Kakinuma, Akira Tsuji, Hiroshi Maéda and Takashi Kano and has published in prestigious journals such as Gastroenterology, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Takuo Ogihara

116 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takuo Ogihara Japan 24 764 723 274 262 215 120 2.1k
Theresia Thalhammer Austria 29 662 0.9× 837 1.2× 204 0.7× 165 0.6× 165 0.8× 79 2.4k
Fanfan Zhou Australia 33 977 1.3× 1.3k 1.8× 273 1.0× 278 1.1× 245 1.1× 140 2.9k
Takanori Hishinuma Japan 25 724 0.9× 728 1.0× 291 1.1× 221 0.8× 250 1.2× 81 2.1k
Nick Plant United Kingdom 28 628 0.8× 995 1.4× 715 2.6× 198 0.8× 103 0.5× 87 2.5k
Shirou Itagaki Japan 23 477 0.6× 857 1.2× 149 0.5× 215 0.8× 229 1.1× 81 2.3k
Emi Nakashima Japan 24 990 1.3× 619 0.9× 214 0.8× 423 1.6× 558 2.6× 98 2.4k
Sandhya Mandlekar United States 28 846 1.1× 2.1k 2.9× 432 1.6× 238 0.9× 216 1.0× 70 3.6k
Karen Ildico Hirsch‐Ernst Germany 24 516 0.7× 712 1.0× 320 1.2× 173 0.7× 191 0.9× 94 2.1k
Akira Ikari Japan 35 461 0.6× 1.5k 2.1× 225 0.8× 191 0.7× 254 1.2× 190 3.6k

Countries citing papers authored by Takuo Ogihara

Since Specialization
Citations

This map shows the geographic impact of Takuo Ogihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takuo Ogihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takuo Ogihara more than expected).

Fields of papers citing papers by Takuo Ogihara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takuo Ogihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takuo Ogihara. The network helps show where Takuo Ogihara may publish in the future.

Co-authorship network of co-authors of Takuo Ogihara

This figure shows the co-authorship network connecting the top 25 collaborators of Takuo Ogihara. A scholar is included among the top collaborators of Takuo Ogihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takuo Ogihara. Takuo Ogihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Okada, Ryo, Norio Masuda, M. Itoh, et al.. (2024). Novel Screening System for Biliary Excretion of Drugs Using Human Cholangiocyte Organoid Monolayers with Directional Drug Transport. Biological and Pharmaceutical Bulletin. 47(2). 427–433. 1 indexed citations
2.
Nakamura, Kentaro, et al.. (2024). Analysis of Protein Digestion and Absorption Using a Ussing Chamber to Simulate the Environment in the Digestive Tract. Journal of Nutritional Science and Vitaminology. 70(2). 158–163. 1 indexed citations
3.
Ogihara, Takuo, et al.. (2024). Mechanism of Induction of P-gp Activity During MET Induced by DEX in Lung Cancer Cell Line. Journal of Pharmaceutical Sciences. 113(6). 1674–1681. 1 indexed citations
4.
Takahashi, Saori, et al.. (2024). Clinical Analysis and <i>in Vitro</i> Correlation of BCRP-Mediated Drug–Drug Interaction in the Gastrointestinal Tract. Biological and Pharmaceutical Bulletin. 47(4). 750–757. 1 indexed citations
5.
Ogihara, Takuo, et al.. (2023). Pharmacokinetics of Biopharmaceuticals: Their Critical Role in Molecular Design. Biomedicines. 11(5). 1456–1456. 3 indexed citations
6.
Furuya, Shinnosuke, et al.. (2023). Transporter and metabolic enzyme-mediated intra-enteric circulation of SN-38, an active metabolite of irinotecan: A new concept. Biochemical and Biophysical Research Communications. 665. 19–25. 5 indexed citations
7.
Ogihara, Takuo, et al.. (2022). Slug Mediates MRP2 Expression in Non-Small Cell Lung Cancer Cells. Biomolecules. 12(6). 806–806. 5 indexed citations
8.
Ito, Masaaki, et al.. (2020). Gastrointestinal absorption of pimozide is enhanced by inhibition of P-glycoprotein. PLoS ONE. 15(10). e0232438–e0232438. 8 indexed citations
9.
Yamada, Hiroyuki, S. Shibata, Eiko Matsumoto, et al.. (2020). Possible utility of peptide-transporter-targeting [19F]dipeptides for visualization of the biodistribution of cancers by nuclear magnetic resonance imaging. International Journal of Pharmaceutics. 586. 119575–119575. 3 indexed citations
10.
Arakawa, Hiroshi, et al.. (2020). Utility of Three-Dimensional Cultures of Primary Human Hepatocytes (Spheroids) as Pharmacokinetic Models. Biomedicines. 8(10). 374–374. 25 indexed citations
13.
Yano, Kentarô, et al.. (2019). Testosterone and androstenedione are endogenous substrates of P-glycoprotein. Biochemical and Biophysical Research Communications. 520(1). 166–170. 20 indexed citations
14.
Katō, Takako, et al.. (2019). Specified Kiwifruit Extract Blocks Increase of Body Weight and Visceral Fat in High-fat-diet-fed Mice by Inhibiting Intestinal Lipase. Food Science and Technology Research. 25(2). 295–302. 5 indexed citations
15.
Machida, Tatsuya, et al.. (2018). Entinostat reverses P-glycoprotein activation in snail-overexpressing adenocarcinoma HCC827 cells. PLoS ONE. 13(7). e0200015–e0200015. 8 indexed citations
16.
Morimoto, Kaori, Yoichiro Ogama, Akihiro Inano, et al.. (2011). Effect of Milk on the Pharmacokinetics of Oseltamivir in Healthy Volunteers. Journal of Pharmaceutical Sciences. 100(9). 3854–3861. 27 indexed citations
17.
Kano, Takashi, et al.. (2011). Pharmacokinetics Parameters in Drug Package Inserts (3). Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 37(9). 543–550. 1 indexed citations
18.
Shiraishi, Tetsuya, Hiroaki Okamoto, Toshihiro Mineta, et al.. (2004). Increased cytotoxicity of soluble Fas ligand by fusing isoleucine zipper motif. Biochemical and Biophysical Research Communications. 322(1). 197–202. 46 indexed citations
20.
Tamai, Ikumi, Takuo Ogihara, Hitomi Takanaga, Hiroshi Maéda, & Akira Tsuji. (2000). Anion antiport mechanism is involved in transport of lactic acid across intestinal epithelial brush-border membrane. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1468(1-2). 285–292. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026